MedPath
NMPA Approval

Pregabalin Capsules

国药准字HJ20230097

August 1, 2023

Drug Information

普瑞巴林胶囊

胶囊剂

75mg

化学药品

August 1, 2023

July 31, 2028

Company Information

Applicant Company

FTO-SEZ, Process Unit-01, Survey No. 57 to 59, 60, 62 &72, Sector No: 9 to 14 & 17 to 20, Devunipalavalasa (V), Ranasthalam (M), Srikakulam District-532409, Andhra Pradesh, India.

Manufacturing Company

FTO-SEZ, Process Unit-01, Survey No. 57 to 59, 60, 62 &72, Sector No: 9 to 14 & 17 to 20, Devunipalavalasa (V), Ranasthalam (M), Srikakulam District-532409, Andhra Pradesh, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

普瑞巴林胶囊 - NMPA 批准文号 | MedPath